Evidence map›Paper›PMID 39125625›Full record

ArticleInternational journal of molecular sciences2024

Diagnostic Potential of

Marlena Janiczek-Polewska, Tomasz Kolenda, Paulina Poter, Joanna Kozłowska-Masłoń, Inga Jagiełło, Katarzyna Regulska, Julian Malicki, Andrzej Marszałek

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marlena Janiczek-PolewskaDepartment of Clinical Oncology, Greater Poland Cancer Centre, 61-866 Poznan, Poland.ORCID 0000-0002-1238-5273
Tomasz KolendaLaboratory of Cancer Genetics, Greater Poland Cancer Centre, 61-866 Poznan, Poland.ORCID 0000-0001-5623-7398
Paulina PoterDepartment of Clinical Pathology, Poznan University of Medical Sciences and Greater Poland Cancer Centre, 61-866 Poznan, Poland.
Joanna Kozłowska-MasłońLaboratory of Cancer Genetics, Greater Poland Cancer Centre, 61-866 Poznan, Poland.ORCID 0000-0001-6914-4852
Inga JagiełłoDepartment of Clinical Pathology, Poznan University of Medical Sciences and Greater Poland Cancer Centre, 61-866 Poznan, Poland.
Katarzyna RegulskaResearch and Implementation Unit, Greater Poland Cancer Centre, 61-866 Poznan, Poland.ORCID 0000-0002-9584-3128
Julian MalickiDepartment of Electroradiology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.ORCID 0000-0002-5558-5558
Andrzej MarszałekDepartment of Clinical Pathology, Poznan University of Medical Sciences and Greater Poland Cancer Centre, 61-866 Poznan, Poland.ORCID 0000-0002-6055-9151

Funding

the National Science Centre, Poland [2022/06/X/NZ5/01813]
6 · The paper itself

Abstract

Gastric cancer (GC) is one of the most frequently diagnosed cancers in the world. Although the incidence is decreasing in developed countries, the treatment results are still unsatisfactory. The standard treatment for locally advanced gastric cancer (LAGC) is gastrectomy with perioperative chemotherapy. The association of selected microRNAs (miRNAs) with chemoresistance was assessed using archival material of patients with LAGC. Histological material was obtained from each patient via a biopsy performed during gastroscopy and then after surgery, which was preceded by four cycles of neoadjuvant chemotherapy (NAC) according to the FLOT or FLO regimen. The expression of selected miRNAs in the tissue material was assessed, including

Indexed as

Drug Resistance, NeoplasmGene Expression Regulation, NeoplasticMicroRNAsStomach NeoplasmsAdultAgedBiomarkers, TumorFemaleGastrectomyHumansMaleMiddle AgedNeoadjuvant TherapyBiomarkers, TumorMicroRNAsMIRN143 microRNA, humanMIRN574 microRNA, humanclinical staginglocally advanced gastric cancermicroRNAsneoadjuvant chemotherapypathological staging

Identifiers

PMID39125625
PMCPMC11311514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.